WORLD UNIVERSITY DIRECTORY
Medical Education FT.com Drugs and Healthcare

  Back to "News Updates - Homepage"


| More


FT.com Drugs and Healthcare - Recent Educational Updates

-->
Trump tariffs bring furrowed brows to Ireland’s Botox town
Westport makes the world’s entire supply of the anti-wrinkle drug — now it fears production could move to the US


Fund for struggling biotechs takes aim at ‘tragedy’ for shareholders
Alis Biosciences then plans to list and offer big investors an easy way to spread their bets


Eli Lilly’s new obesity pill lowers blood sugar and aids weight loss
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%


Trump pledges to cut drug prices for Americans
Latest executive order could shake up US pharma industry


J&J warns pharma tariffs could cause drug shortages
Medical devices like group’s surgical robots have already been hit by the new US charges


Pfizer to halt development of closely watched weight-loss drug
US pharmaceutical group says patient in study experienced ‘potential drug-induced liver injury’


How policies in Ireland and Chile hit disabled people’s job prospects
The European nation has one of the largest employment gaps among OECD members and compares poorly against the South American country


Progress on disability employment is at risk under Trump policies
The US administration seeks to dismantle DEI programmes that provide customised equipment and infrastructure at work


Rosie Jones: ‘I was a disabled person who didn’t know the meaning of ableism’
At 21 and fresh out of university, I was grateful to have a job. Even now, discrimination of people with disabilities remains


AI-powered bionic limbs come at too high a cost for many
Amputees, among the largest minority at work, highlight the need for assistive technology to be affordable and accessible


NHS signs deal with Scancell in ambitious skin cancer trial
Move comes as government seeks to boost UK’s standing as drugs research leader


England’s busiest A&E department grapples with soaring demand for elderly care
A Leicester hospital is trialling a fresh approach to caring for older patients as demographic shifts loom


Trade war could put the frown back on Botox users’ faces
Fears that pharmaceuticals could yet be hit by tariffs have sent shares sharply lower


Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D
Pharma group builds out American supply chains as part of preparations for potential US tariffs


Scientists recreate brain circuit in lab for first time
Research breakthrough promises new treatments for severe pain


KKR strikes €2.6bn deal with EQT for E45 maker Karo Healthcare
US private equity group beats rival bid from PAI Partners for Stockholm-based healthcare company


NHS landlord agrees £1.6bn takeover by KKR consortium
Assura rejects rival offer that would have kept it in the public markets


Many NHS staff struggle to use electronic records effectively, report finds
Poor training and lack of investment are main challenges to successful deployment, says think-tank


Bain Capital clinches $2.6bn deal to buy Blackstone-backed HealthEdge
Sale of US healthcare software company grants two-fold return on investment


Universities should not be greedy with technology spin-offs
Letting software and life sciences companies emerge from research has long-term benefits for academic institutions


Starmer pledges centralised service for researchers to mine health data
Announcement follows recommendation in UK government-commissioned review last year


How to restore trust in doctors in an age of misinformation
Healthcare workers and officials say falsehoods and conspiracy theories cost lives and are exacerbating inequalities


A dark hour for American science
Other countries have a chance to attract US talent driven out by Trump’s policies


Wellness is the new status symbol — but the quest has its downsides
In this booming industry it can be hard to know when you’re being sold snake oil


Focus on stigma not risk to bring down the suicide rate
The new prevention strategy must — this time — be implemented